Monte Rosa Therapeutics, Inc.
GLUENASDAQHealthcare● Active
$16.87
+$0.50(+3.05%)
Market Cap$1.1B
P/E Ratio—
52W High$25.77
52W Low$4.12
Monte Rosa Therapeutics, Inc.（GLUE）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · GLUE · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.12B | $0.08B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Gross Profit | $0.12B | $0.07B | ($0.01B) | $0.00B | $0.00B |
| Gross Margin %(computed) | 93.24% | 89.26% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.14B | $0.12B | $0.11B | $0.09B | $0.06B |
| G&A Expenses | $0.04B | $0.04B | $0.03B | $0.03B | $0.02B |
| Total Operating Expenses | $0.17B | $0.15B | $0.14B | $0.11B | $0.07B |
| Operating Income | ($0.05B) | ($0.08B) | ($0.14B) | ($0.11B) | ($0.07B) |
| Operating Margin %(computed) | -43.83% | -107.26% | — | — | — |
| Interest Income | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.04B) | ($0.07B) | ($0.14B) | ($0.11B) | ($0.07B) |
| Income Tax Expense | ($0.00B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.04B) | ($0.07B) | ($0.14B) | ($0.11B) | ($0.07B) |
| Net Margin %(computed) | -31.23% | -96.14% | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.46 | $-0.98 | $-2.63 | $-2.30 | $-1.59 |
| Wtd Avg Shares | 0.08B | 0.07B | 0.05B | 0.05B | 0.05B |
| EBITDA | ($0.05B) | ($0.07B) | ($0.14B) | ($0.11B) | ($0.07B) |
| EBITDA Margin %(computed) | -37.08% | -96.52% | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Monte Rosa Therapeutics, Inc.
关于Monte Rosa Therapeutics, Inc.（GLUE）损益表
Monte Rosa Therapeutics, Inc.（GLUE）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，GLUE实现营收$0.12B，毛利润$0.12B（毛利率93.24%），净利润($0.04B)（净利率-31.23%）。
常见问题
GLUE · 4 问Monte Rosa Therapeutics, Inc.（GLUE）2025财年营收为$0.12B，同比up63.5%。
GLUE revenueGLUE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08